Question to the Department of Health and Social Care:
To ask His Majesty's Government what assessment they have made of the NHS costs incurred by sending thyroid patients to secondary care for liothyronine, given NHS England national guidance only requires initiation of treatment in secondary care but allows regular prescribing in primary care.
No specific assessments have been made of the costs of reviewing patients currently prescribed liothyronine in secondary care.